v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 18,096 $ 27,554
Restricted cash 6,000 6,000
Investments 3,973 5,928
Accounts receivable, net of allowance for doubtful accounts of $960 and $788, respectively 26,295 24,105
Inventory 35,504 33,183
Prepaid expenses and other 3,202 2,447
Total current assets 93,070 99,217
Property and equipment, net 83,311 84,667
Operating lease right-of-use assets 13,903 14,265
Intangible assets, net 5,881 5,579
Total assets 196,165 203,728
Current liabilities:    
Accounts payable and accrued expenses 19,658 28,641
Current maturities of long-term lease obligations 2,087 1,969
Total current liabilities 21,745 30,610
Long-term debt, net of debt discount and financing fees 47,716 47,496
Long-term lease obligations 18,640 19,221
Debt derivative liabilities 2,558 2,400
Other long-term liabilities 141 94
Total liabilities 90,800 99,821
Commitments and contingencies - see Note 13
Shareholders’ equity:    
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 45,512,623 and 44,148,836 shares issued and outstanding 455 441
Additional paid-in capital 400,004 394,726
Accumulated deficit (295,094) (291,260)
Total shareholders’ equity 105,365 103,907
Total liabilities and shareholders’ equity $ 196,165 $ 203,728

Source

v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 48,560 $ 41,378
Cost of goods sold 13,627 8,758
Gross profit 34,933 32,620
Costs and expenses:    
Sales and marketing 21,045 19,815
Research and development 6,091 7,409
General and administrative 9,458 9,956
Total costs and expenses 36,594 37,180
Loss from operations (1,661) (4,560)
Other (expense) income:    
Investment income 272 293
Interest expense (2,250) (2,326)
Change in fair value of debt derivative liabilities (158) 65
Other expense (37) (107)
Total other expense, net (2,173) (2,075)
Net loss $ (3,834) $ (6,635)
Weighted average common shares outstanding - basic (in shares) 45,204,076 43,233,149
Weighted average common shares outstanding - diluted (in shares) 45,204,076 43,233,149
Net loss per common share - basic (in USD per share) $ (0.08) $ (0.15)
Net loss per common share - diluted (in USD per share) $ (0.08) $ (0.15)

Source

v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (3,834) $ (6,635)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,728 1,520
Amortization of right-of-use assets 87 315
Amortization of intangible assets 67 62
Amortization of debt discount and deferred financing fees 220 222
Provision for bad debts 187 255
Change in fair value of debt derivative liabilities 158 (65)
Investment gains (45) (10)
Stock-based compensation 2,909 3,919
Change in operating assets and liabilities:    
Accounts receivable (2,377) 681
Inventory (2,321) (4,616)
Prepaid expenses and other (489) (262)
Accounts payable and accrued expenses (9,079) (7,291)
Operating lease obligations (452) (360)
Cash paid for interest portion of financing lease obligations (1) (1)
Other long-term liabilities 63 0
Net cash used in operating activities (13,179) (12,266)
Cash flows from investing activities:    
Purchase of property and equipment (256) (924)
Purchase of investments 0 (1,910)
Proceeds from sale of investments 2,000 0
Cash payments for intangible assets (405) (417)
Net cash provided by (used in) investing activities 1,339 (3,251)
Cash flows from financing activities:    
Cash paid for debt portion of financing lease obligations (1) (3)
Proceeds from exercise of stock options and ESPP stock purchases 2,383 207
Net cash provided by financing activities 2,382 204
Net decrease in cash and cash equivalents, and restricted cash (9,458) (15,313)
Cash and cash equivalents, and restricted cash, beginning of period 33,554 37,026
Cash and cash equivalents, and restricted cash, end of period 24,096 21,713
Supplemental disclosures of cash flow activity:    
Cash paid for interest 1,513 1,656
Supplemental disclosure of noncash investing and financing activities:    
Acquisition of property and equipment in accounts payable and accrued expenses 116 516
Acquisition of intangible assets in accounts payable and accrued expenses $ (36) $ 290

Source